These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14514656)

  • 1. Dietary retinoic acid supplementation stimulates intestinal tumour formation and growth in multiple intestinal neoplasia (Min)/+ mice.
    Møllersen L; Paulsen JE; Olstørn HB; Knutsen HK; Alexander J
    Carcinogenesis; 2004 Jan; 25(1):149-53. PubMed ID: 14514656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promotion of adenoma growth by dietary inulin is associated with increase in cyclin D1 and decrease in adhesion proteins in Min/+ mice mucosa.
    Misikangas M; Pajari AM; Päivärinta E; Mutanen M
    J Nutr Biochem; 2005 Jul; 16(7):402-9. PubMed ID: 15992678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiposity-related protection of intestinal tumorigenesis: interaction with dietary calcium.
    Ding S; McEntee MF; Whelan J; Zemel M
    Nutr Cancer; 2007; 58(2):153-61. PubMed ID: 17640161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of gastric tumors in Apc(Min/+) mice by the activation of the beta-catenin/Tcf signaling pathway.
    Tomita H; Yamada Y; Oyama T; Hata K; Hirose Y; Hara A; Kunisada T; Sugiyama Y; Adachi Y; Linhart H; Mori H
    Cancer Res; 2007 May; 67(9):4079-87. PubMed ID: 17483318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of nucleotide excision repair deficiency in intestinal tumorigenesis in multiple intestinal neoplasia (Min) mice.
    Steffensen IL; Schut HA; Nesland JM; Tanaka K; Alexander J
    Mutat Res; 2006 Dec; 611(1-2):71-82. PubMed ID: 16962818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of aberrant (cytoplasmic/nuclear) expression of beta-catenin in pancreatoblastoma.
    Tanaka Y; Kato K; Notohara K; Nakatani Y; Miyake T; Ijiri R; Nishimata S; Ishida Y; Kigasawa H; Ohama Y; Tsukayama C; Kobayashi Y; Horie H
    J Pathol; 2003 Feb; 199(2):185-90. PubMed ID: 12533831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids.
    Schmelz EM; Roberts PC; Kustin EM; Lemonnier LA; Sullards MC; Dillehay DL; Merrill AH
    Cancer Res; 2001 Sep; 61(18):6723-9. PubMed ID: 11559543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of PPARbeta/delta and cyclin D1 in flat dysplastic ACF and adenomas in Apc(Min/+) mice.
    Knutsen HK; Olstørn HB; Paulsen JE; Husøy T; Goverud IL; Løberg EM; Kristiansen K; Alexander J
    Anticancer Res; 2005; 25(6B):3781-9. PubMed ID: 16309164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age at exposure and Apc status influence the levels of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-DNA adducts in mouse intestine and liver.
    Steffensen IL; Schut HA; Alexander J
    Mutat Res; 2005 Nov; 587(1-2):73-89. PubMed ID: 16202642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1 is not an essential target of beta-catenin signaling during intestinal tumorigenesis, but it may act as a modifier of disease severity in multiple intestinal neoplasia (Min) mice.
    Wilding J; Straub J; Bee J; Churchman M; Bodmer W; Dickson C; Tomlinson I; Ilyas M
    Cancer Res; 2002 Aug; 62(16):4562-5. PubMed ID: 12183406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apc gene mutation is associated with a dominant-negative effect upon intestinal cell migration.
    Mahmoud NN; Boolbol SK; Bilinski RT; Martucci C; Chadburn A; Bertagnolli MM
    Cancer Res; 1997 Nov; 57(22):5045-50. PubMed ID: 9371501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induces genetic changes in murine intestinal tumours and cells with ApcMin mutation.
    Andreassen A; Vikse R; Mikalsen A; Adamovic T; Steffensen IL; Hjertholm H; Levan G; Alexander J
    Mutat Res; 2006 Apr; 604(1-2):60-70. PubMed ID: 16574467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARdelta status and Apc-mediated tumourigenesis in the mouse intestine.
    Reed KR; Sansom OJ; Hayes AJ; Gescher AJ; Winton DJ; Peters JM; Clarke AR
    Oncogene; 2004 Nov; 23(55):8992-6. PubMed ID: 15480419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development.
    Nateri AS; Spencer-Dene B; Behrens A
    Nature; 2005 Sep; 437(7056):281-5. PubMed ID: 16007074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of intestinal polyposis in Mdr1-deficient ApcMin/+ mice.
    Yamada T; Mori Y; Hayashi R; Takada M; Ino Y; Naishiro Y; Kondo T; Hirohashi S
    Cancer Res; 2003 Mar; 63(5):895-901. PubMed ID: 12615699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth stimulation of intestinal tumours in Apc(Min/+) mice by dietary L-methionine supplementation.
    Paulsen JE; Alexander J
    Anticancer Res; 2001; 21(5):3281-4. PubMed ID: 11848484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinol decreases beta-catenin protein levels in retinoic acid-resistant colon cancer cell lines.
    Dillard AC; Lane MA
    Mol Carcinog; 2007 Apr; 46(4):315-29. PubMed ID: 17219422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of genetic background on spontaneous or 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced intestinal tumorigenesis in Min/+ mice.
    Steffensen IL; Alexander J
    Cancer Lett; 2006 Aug; 240(2):289-96. PubMed ID: 16343741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
    Li Q; Ishikawa TO; Oshima M; Taketo MM
    Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype-phenotype correlation in murine Apc mutation: differences in enterocyte migration and response to sulindac.
    Mahmoud NN; Bilinski RT; Churchill MR; Edelmann W; Kucherlapati R; Bertagnolli MM
    Cancer Res; 1999 Jan; 59(2):353-9. PubMed ID: 9927046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.